Data as of Aug 28
| +0.81 / +2.56%|
The 4 analysts offering 12-month price forecasts for Medifast Inc have a median target of 30.50, with a high estimate of 34.00 and a low estimate of 24.90. The median estimate represents a -5.84% decrease from the last price of 32.39.
The current consensus among 4 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.